Brief: Aap Implantate: FY Sales Up At EUR 12.2 Mln

aap Implantate AG

31/03/2022 06:25

March 31 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * FY EBITDA LOSS ROSE 84 PERCENT TO -800,000 EUR
    * FY SALES ROSE 30 PERCENT TO 12.2 MILLION EUR
    * OUTLOOK FY/2022: SALES BETWEEN EUR 14.0 AND 16.0 MILLION
(+15%
TO +31%) AS WELL AS POSITIVE EBITDA AND ALMOST BALANCED FREE
CASH FLOW PLANNED FOR FIRST TIME FOR ENTIRE COMPANY (EXCLUDING.
COSTS SILVER, ESP. HUMAN CLINICAL STUDY)
    * BASED ON A STRONG IMPROVEMENT IN OPERATING PROFIT, FY
OPERATING
CASH FLOW ALSO IMPROVED SIGNIFICANTLY BY +33% TO EUR -2.5
MILLION
    * SHOWS A SOLID FY EQUITY RATIO OF 56% (+4 PP) AS OF 31
DECEMBER
2021

Source text for Eikon:  ID:nEQ4tgjyBa 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))